Cabozantinib in patients (pts) with non-locally pretreated brain metastases (BM) from renal cell carcinoma (RCC): Results of the multicenter CABRAMET phase II trial (NCT03967522).
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sylvie Negrier, Loic Mourey, Ellen Blanc, Marine Gross-Goupil, Aude Flechon, Ronan Flippot, Philippe Barthelemy, Stephane Oudard, Emeline Colomba, Constance Thibault, Alain Ravaud, Christine Chevreau, Mathilde Donnat, Helen Jane Boyle, Cécile Dalban, David Pérol, Bernard Escudier, Laurence Albiges, GETUG investigators
Institutions: Université de Lyon, Centre Léon Bérard, Institut Claudius Regaud, Centre Hospitalier Universitaire de Bordeaux, Institut Gustave Roussy, Fondation Gustave Roussy, Institut de Cancérologie Strasbourg, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Université de Bordeaux
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407699796